Arxxant is an investigational drug, ruboxistaurin mesylate reduced the occurrence of vision loss in patients with diabetic retinopathy. Elli Lilly and Company is waiting for the approval of Arxxant for the treatment of Diabetic Retinopathy, the initial indication for ruboxistaurin from the United States Food & Drug Administration (FDA). The phase 3 clinical trails of Arxxant are completed.
Arxxant reduced the risk of vision loss in diabetics by nearly 41 percent, according to data...
| Currently you cannot purchase Arxsant as it might be not available for sale online or on local pharmacy. Subscribe below and we will inform you where and when you can order Arxsant |
| Arxsant Availability Subscription Form |
|
| |
| Note: We will email you when Arxsant is available for sale online or in pharmacy in your country. |
|
|
|